Under-the-Radar Stem Cell Stock with Real Revenue

This isn't another zero-revenue biotech. They've already launched a commercial product-and now their lead therapy just got FDA Fast Track.

Popular

Elon Musk Recently Said 'Yes' To Impeaching Trump And The Odds Of That Happening In 2025 Rose On This Crypto Betting Market

The odds that President Donald Trump would be impeached this year saw a spike on Polymarket after tech mogul Elon Musk backed a call to remove him from office. 

Technical Reversal Setting up for Security Microcap - Ad

A descending wedge, flat support, and insider buying. All signs point to a technical breakout on this C$0.35 AI stock.

Takeaways from AP's report on the business interests of Trump's surgeon general pick

PROVIDENCE, R.I. (AP) — President Donald Trump’s pick to be U.S. surgeon general has repeatedly said the nation’s medical and food systems are corrupted by special interests and people out to make a profit at the expense of Americans’ health. Yet as has criticized scientists, medical schools and regulators for taking money from the food and pharmaceutical industries, she has promoted dozens of products in ways that put money in her own pocket.

Safety Act Could Unlock Federal Goldmine - Ad

SAFETY Act certification could open the floodgates. The company's already in. Traders are watching.

50-Year Legend: Here's the Day Stocks Likely Crash - Ad

Legendary quant analyst Marc Chaikin says in 50 years on Wall Street, one stock cycle indicator worked better than anything else. It's been studied by Schwab, T.Rowe, Goldman, and more. And now Chaikin is sounding the alarm because this cycle indicator is pointing to March 2026 for the next big crash.

British Man Charged In US With Spying For China — Here's How He Allegedly Did It

A British man has been indicted in the U.S. on charges of espionage for China. The accused, John Miller, is facing multiple charges including interstate stalking and smuggling.

How To Earn $500 A Month From Broadcom Stock Ahead Of Q2 Earnings

Broadcom offers an annual dividend yield of 0.90% ($2.36 a year). To figure out how to earn $500 monthly, here's what you do.

Under-the-Radar Stem Cell Stock with Real Revenue - Ad

This isn't another zero-revenue biotech. They've already launched a commercial product-and now their lead therapy just got FDA Fast Track.

Cloudflare Strengthening, Yet Breakout Unlikely Until 2026

Cloudflare Stock: Structure remains constructive, but a breakout may not unfold until March 2026.

A judge tells federal agencies they can't enforce anti-trans bias policies against Catholic groups

BISMARCK, N.D. (AP) — Two federal agencies cannot punish Catholic employers and health care providers if they refuse for religious reasons to provide gender-affirming care to transgender patients or won't provide health insurance coverage for such care to their workers, a federal judge ruled Thursday.

TSA-Approved. Government-Tested. Market-Ignored. - Ad

Already deployed across the US and tested by US government agencies, US Military and NATO countries, this microcap trades under C$0.35.

China's exports climb 4.8% in May as shipments to the US fall nearly 10%

BEIJING (AP) — China's exports rose 4.8% in May from a year earlier, a bit lower than expected as shipments to the United States fell nearly 10%, according to customs figures released Monday just hours ahead of another round of between the U.S. and China.

Tiny Float. Big Potential. Hidden Biotech. - Ad

With a float under 5M shares and insiders holding over 27%, this microcap is primed. The chart is coiling and the data is strong.

Britain is getting a defense boost aimed at sending a message to Moscow, and to Trump

LONDON (AP) — The United Kingdom will build new nuclear-powered attack submarines and create an army ready to fight a war in Europe as part of designed to send a message to Moscow — and Washington.

Sam Bankman-Fried's Early Release, Schiff Vs Vance, Bitcoin's Fall, And Trump's Meme Coin Dinner: This Week In Crypto

The past week was a rollercoaster ride in the world of finance and cryptocurrency. From the early release of a notorious fraudster to a heated debate over Bitcoin’s value, the weekend was packed with intriguing stories. Here’s a quick recap of the top stories that made headlines. Sam Bankman-Fried’s Early Release

This Microcap May Leapfrog a $1.46B Stem Cell Giant - Ad

One has Fast Track status and real data. The other has a billion-dollar valuation and FDA rejection. Guess which one trades for pennies?

US and Europe trade negotiators discuss tariffs in Paris

PARIS (AP) — Europe and the United States are meeting in Paris to negotiate a settlement of a tense tariff spat with global economic ramifications between two global economic powerhouses.

Chart Watchers Are Circling This Biotech Setup - Ad

The 10/20/50/200 MAs are converging. A symmetrical wedge is tightening. One catalyst, and this low-float biotech could have plenty of upside potential.

US Military Just Validated This AI Threat Detection Stock - Ad

A $12M security stock just passed one of the toughest national security tests out there - spotting hidden IEDs, plastic explosives, and non-metallic weapons with over 90% accuracy in US military trials. Now it's rolling out in airports, courthouses, and federal labs.

Trump's surgeon general pick criticizes others' conflicts but profits from wellness product sales

PROVIDENCE, R.I. (AP) — President Donald Trump’s pick to be the next U.S. surgeon general has repeatedly said the nation’s medical, health and food systems are corrupted by special interests and people out to make a profit at the expense of Americans’ health.

FDA Fast Track for a $1.60 Stem Cell Underdog - Ad

A tiny biotech with a novel stem cell injection just got Fast Track status. Early data shows over 50% pain reduction in 70% of patients-no surgery, no donor cells. Analysts are waking up. You should too.

MongoDB Is Poised To 'Emerge As A Winner In The AI Revolution': Analysts

Shares of MongoDB rallied in early trading on Thursday, after the company Wednesday reported upbeat fiscal first-quarter results.

The $5.7m TSA Bet You Haven't Heard Of - Ad

One AI scanner just received $5.7M in TSA funding. It detects threats others miss - and trades at a 98% discount to Evolv.

Rocket Lab, AST SpaceMobile, Virgin Galactic Shares Are Rising After Hours: What's Going On?

Space stocks are rising in Thursday's after-hours session amid an escalation of a public dispute between SpaceX's Elon Musk and President Donald Trump.

Can an American pope apply US-style fundraising and standards to fix troubled Vatican finances?

VATICAN CITY (AP) — As a bishop in Peru, Robert Prevost was often on the lookout for used cars that he could buy cheap and fix up himself for use in parishes around his diocese. With cars that were really broken down, he’d watch YouTube videos to learn how to fix them.

Technical Reversal Setting up for Security Microcap - Ad

A descending wedge, flat support, and insider buying. All signs point to a technical breakout on this C$0.35 AI stock.

Palantir CEO Warns US-China AI Race Will Have One Winner, Urges West To Keep Up

PLTR CEO Karp believes US will win AI race with China, expressing concerns about its dangers while acknowledging its benefits. Stock down.

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright markethundred.com
Privacy Policy | Terms of Service